Select Page

Measuring the cannabis consumer experience: Q&A with Israel Gasperin, CEO, Zentrela

Grow Opportunity, Media Partners

This post is presented by our media partner Grow Opportunity
View the full article here.

Zentrela, the Ontario-based biotech company used for measuring cannabis consumer experience, is described by founder and CEO Israel Gasperin as “cannabis effect education,” stating that their mission is “to become the most trustworthy provider of cannabis effect information for the consumer, the retailer and the producer.”

Zentrela’s neurotechnology platform is the first scientifically proven test to objectively quantify cannabis psychoactive effects. The company is providing a brain wave monitoring technology to assist licensed producers make scientific claims about products, help retailers educate consumers, and eventually, to be used by employers and law enforcement to determine intoxication levels in the public.

GO: Israel, describe the process in founding Zentrela.

IG: My background is in software engineering. And I used to work in the financial sector back in Mexico, which is where I am from, and I always wanted to start a business.

I have always been passionate about neuroscience, meditation, mindfulness. So when I combined all of that, I decided to study a master’s in entrepreneurship here in Canada to transition from working in the financial sector to starting up the business.


The wearable brain technology or EEG was initially designed for the detection of driver fatigue. I graduated from my master’s degree in 2016 and was told that cannabis would be legalized and there is nothing that tests actual impairment.

So that was the kind of ‘aha moment’ to focus on cannabis impairment detection rather than driver fatigue detection. And during 2016 and 2018, we focused on building this technology which basically, in a nutshell, what we are doing is conducting research to record the brain activity of this subjects and then scientifically characterize it in an accurate way — what consumers or test subjects are experiencing.

And then based on these large data sets of electrical brain activity, we are using machine learning to detect specific brain activity and alterations that happen when the THC gets to the brain and creates that psychoactive experience.

GO: When did you begin working with the cannabis industry in Canada?

IG: In 2018, we were also meeting with licensed producers, including Alex Revich who I reached out to and since then he has been supporting us and today is officially a part of our advisory board.

Based on the format and different amounts of THC, and combined with other cannabinoids, all of that is impacting the speed, the potency the duration of the psychoactive effects. So, in 2021 when we published the results and I learned about this commercial application, we also had the opportunity to raise a close to one million dollars from our existing angel investor who supported this commercialization strategy, which consists of focusing on the recreational market, continuing building more research evidence about our EEG approach to characterize cannabis effects.

The vision here is that we believe that if consumers retailers and producers from their recreational market adopt this approach, as a as an objective and reliable way of describing products’ effects, then we believe that the next organic or natural adoption will be the other markets maybe for therapeutic and medical research, workplace safety and law enforcement.

We believe there is an unmet address in the global recreational, even medical, but that’s different in the recreational cannabis market. Right now, there doesn’t exist science-backed product information that consumers can use to make a purchase or consumption decision. Budtenders cannot freely speak about them so they cannot support consumers in retail.

Many people still believe that the government prohibits speaking about product effects, and in that’s not true, the government has imposed or specified strict regulations. If you want to make a product characteristic claim, it must be backed with scientific research – you prove that it is factual.

GO: Are licensed producers already making claims about their products through Zentrela’s data?

IG: Yes, we are already doing it; the regulations are already in place.

In the Cannabis Act, there is a section for information that promotion of cannabis products and then they outline what are what is the criteria that you need you need to meet in order to make such claims. So we’ve been working with producers and this has already been happening since almost one year and a half ago.

And now, what we just recently announced last week is now an independent initiative from Zentrela to say, okay, we are the ones funding the research and we have all these results. We can share it with the producer. Also we can share it directly with the retailer.

So the retailer meets the mandate of educating the consumer and supporting them to make informed decisions while at the same time they benefit by moving products faster. And then also by posting these through age gated media magazines or our Instagram account, etc.

We are creating new line of communication between Zentrella and the consumer. 

GO: What is the timeline before we are seeing someone like the OCS helping consumers make decisions based on Zentrela data?

IG: That is a great question because we can look for a big collaboration or partnership with the Ontario Cannabis Store in order to see how we can also share our data through the platform. We are looking for that kind of collaboration with them. We haven’t yet but we believe that it’s underway. All of that information could become accessible to the consumer and they can help us to distribute this kind of content if they want to participate.

As a startup, we’re exploring whether there is any other interest from other provinces or internationally.

I think that the interest or the value here, really, is directed to the Canadian market – that they have access to the products that we are installing. For example, we just posted three fast acting beverages and any province that has access to these products, we welcome the opportunity to partner with the with the provincial stores and equip them with this content.

Photo: Israel Gasperin, founder & CEO, Zentrela

This post was originally published by our media partner here.